| Patient | Richard Roundtree |
|---|---|
| Date of birth | 1942-07-09 |
| Identifiers | MRN HR-ML015-SYN-TD; SSN (made up) 000-15-8410 |
| Document date | 1993-10-05 |
| Author | Leon Carrington, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Biopsy results for a left breast lump. [S]
Mr. Roundtree returns six days after first coming in with a painless lump under the left nipple. Diagnostic mammography and ultrasound of both breasts and both axillae the next day showed a 1.6 cm irregular mass eccentric to the left nipple and one abnormal left axillary lymph node; the right breast and axilla were normal. Core biopsies of the mass and the node the same day show invasive ductal carcinoma, grade 3, estrogen receptor 95 percent, progesterone receptor 85 percent, HER2 negative, with cancer in the node. He was asked to come in so the result could be given in person. He says he had not thought a man could get breast cancer and had been sure it was the breast enlargement he had at 13. He has no bone pain, cough, headache, abdominal pain, or weight loss. He saw Dr. Siddiqui of breast surgical oncology this morning, and the operation is booked in two days. His main worries are the operation, whether he can keep working, and keeping the diagnosis private. [S]
| Element | Detail |
|---|---|
| Diagnosis | Invasive ductal carcinoma, left breast, grade 3, ER and PR positive, HER2 negative; left axillary node positive |
| Other breast and axilla | Normal on mammography and ultrasound |
| Symptoms of spread | None |
| Coordination | Surgical oncology seen today; operation in two days |
| Concerns | The operation, work, and privacy |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Respiratory | Negative | No cough or breathlessness |
| Musculoskeletal | Negative | No bone pain |
| Neurological | Negative | No headache or weakness |
| Gastrointestinal | Negative | No abdominal pain |
| Psychiatric | Positive | Worried and shaken; sleeping less; PHQ-9 score 5; no thoughts of self-harm |
6 systems reviewed. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1993-10-05 | Body height | 188 | cm | S |
| 1993-10-05 | Body weight | 85.6 | kg | S |
| 1993-10-05 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 1993-10-05 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1993-10-05 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1993-10-05 | Heart rate | 82 | /min | S |
| 1993-10-05 | Respiratory rate | 16 | /min | S |
| 1993-10-05 | Body temperature | 36.8 | Cel | S |
| 1993-10-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1993-10-05 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1993-10-05 | Leukocytes [#/volume] in Blood by Automated count | 6.6 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1993-10-05 | Neutrophils [#/volume] in Blood by Automated count | 3.9 | 10*3/uL | 1.5-7.7 10*3/uL | Normal | S |
| 1993-10-05 | Platelets [#/volume] in Blood by Automated count | 246 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1993-10-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1993-10-05 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1993-10-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1993-10-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1988)/1.73 sq M | 89 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1993-10-05 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1993-10-05 | Calcium [Mass/volume] in Serum or Plasma | 9.5 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1993-10-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 1993-10-05 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 8-48 U/L | Normal | S |
| 1993-10-05 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 71 | U/L | 40-129 U/L | Normal | S |
| 1993-10-05 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1993-10-05 | Albumin [Mass/volume] in Serum or Plasma | 4.4 | g/dL | 3.5-5 g/dL | Normal | S |
| 1993-10-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Vital signs recorded on 1993-10-05; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; anxious but composed |
| Breasts | Left: 1.5 cm firm, irregular, painless mass eccentric to the nipple at 2 o'clock, not fixed to the chest wall; mild bruising from the biopsy; no nipple retraction or discharge. Right: no mass and no glandular enlargement |
| Lymph nodes | One firm, mobile 1 cm left axillary node; no right axillary, supraclavicular, or cervical nodes |
| Abdomen | Soft; liver not enlarged |
| Musculoskeletal | No spinal tenderness |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast cancer | active | confirmed | C50.122 | S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D). |
| Estrogen receptor-positive status of the breast cancer | active | confirmed | Z17.0 | S — Synthetic receptor result; his tumor biology was not made public. |
| New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy booked | resolved | confirmed | N63.42 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Diagnostic mammography and ultrasound of both breasts and both axillae | At diagnosis | Up to date | Done the day after the first visit: left mass BI-RADS 5 with one abnormal node; right breast and axilla normal |
| Laboratory | Core biopsy with ER, PR, and HER2 status | At diagnosis | Up to date | Invasive ductal carcinoma, grade 3, ER 95 percent, PR 85 percent, HER2 1+ (negative), Ki-67 30 percent; node positive |
| Laboratory | Preoperative blood count and chemistry | Before surgery | Completed today | All normal: hemoglobin 14.8 g/dL, platelets 246, creatinine 1.02 mg/dL, eGFR 89, calcium 9.5 mg/dL, ALT 24 and alkaline phosphatase 71 U/L |
| Imaging | Staging CT, bone scan, or PET | Only for clinical stage III or symptoms or abnormal results suggesting spread | Not indicated | Clinical stage IIA with no symptoms and normal calcium, alkaline phosphatase, and liver tests |
| Laboratory | Germline multigene panel testing | Once, for every man with breast cancer | Ordered | Sent today; the result is not needed before surgery |
| Referral | Breast surgical oncology | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Examination | Baseline arm circumference before axillary surgery | Once, before axillary surgery | Deferred | Not measured today, a deviation from the protocol; the visit was taken up with the diagnosis and the plan. To be addressed after surgery |
| Survey | Distress and depression screen (PHQ-9) | At diagnosis and each visit | Completed today | PHQ-9 score 5, mild, with worry about the operation and work; no thoughts of self-harm |
| Self-management | Information and support | At diagnosis | Completed today | Told plainly that men get breast cancer and that it is treated as well in men as in women; written information for men with breast cancer and details of a peer-support group given; confidential handling of his records and a work note offered |
Goal progress:
Guideline basis: Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020); NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Bedrosian I, et al. Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024;42(5):584-604 (2024); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)
Follow-up: Surgery in two days. Primary care review about two weeks after surgery, after the pathology. Medical oncology after the pathology. Call the surgical team for fever, wound redness, or a swelling under the arm. Next scheduled visit 1993-10-20: review two weeks after mastectomy and axillary dissection: pathology, wound and arm care, and preparation for chemotherapy. [S]